The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance-Reference-Cited by-同舟云学术

The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance

Published:2021-07 Issue:7 Volume:39 Page:999-1014.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Joshi Sunil K.^ORCID,Nechiporuk Tamilla,Bottomly Daniel,Piehowski Paul D.,Reisz Julie A.,Pittsenbarger Janét,Kaempf Andy,Gosline Sara J.C.,Wang Yi-Ting,Hansen Joshua R.,Gritsenko Marina A.,Hutchinson Chelsea,Weitz Karl K.,Moon Jamie,Cendali Francesca^ORCID,Fillmore Thomas L.,Tsai Chia-Feng^ORCID,Schepmoes Athena A.^ORCID,Shi Tujin,Arshad Osama A.,McDermott Jason E.,Babur Ozgun^ORCID,Watanabe-Smith Kevin^ORCID,Demir Emek^ORCID,D'Alessandro Angelo,Liu Tao^ORCID,Tognon Cristina E.,Tyner Jeffrey W.,McWeeney Shannon K.^ORCID,Rodland Karin D.^ORCID,Druker Brian J.^ORCID,Traer Elie

Funder

American Cancer Society

NCI

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference103 articles.

1. Integrating biological pathways and genomic profiles with ChiBE 2;Babur;BMC Genomics,2014

2. ChiBE: interactive visualization and manipulation of BioPAX pathway models;Babur;Bioinformatics,2010

3. Causal Interactions from Proteomic Profiles: Molecular Data Meets Pathway Knowledge;Babur,2018

4. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma;Banelli;Cell Cycle,2015

5. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth;Battula;JCI Insight,2017

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MetMiner: A user‐friendly pipeline for large‐scale plant metabolomics data analysis;Journal of Integrative Plant Biology;2024-09-10

2. Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors;Experimental Hematology;2024-09

3. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

4. A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer;Cell Chemical Biology;2024-09

5. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis;Cell Communication and Signaling;2024-08-07